Women's College Research Institute, Toronto, ON, Canada.
Int J Cancer. 2013 Aug 1;133(3):730-9. doi: 10.1002/ijc.28064. Epub 2013 Mar 13.
Differentiating ovarian tumors based on developmental pathway may further enhance our understanding of the disease. Traditionally, ovarian cancers were thought to arise from the ovarian surface epithelium; however, recent evidence suggests that some tumors originate in the fallopian tube. We classified cases in a population-based case-control study (New England Case-Control [NECC] Study) and two cohort studies (Nurses' Health Study [NHS]/Nurses' Health Study II [NHSII]) by tumor dominance, a proxy for tissue of origin. Dominant tumors (likely ovarian origin) are restricted to one ovary or are at least twice as large on one ovary compared to the other. Ovarian cancer risk factors were evaluated in relation to dominant and nondominant tumors (likely tubal origin) using polytomous logistic regression (NECC) or competing risks Cox models (NHS/NHSII). Results were combined using random-effects meta-analyses. Among 1,771 invasive epithelial ovarian cancer cases, we observed 1,089 tumors with a dominant mass and 682 with no dominant mass. Dominant tumors were more likely to be mucinous, endometrioid or clear cell, whereas nondominant tumors were more likely to be serous. Tubal ligation, two or more births, endometriosis and age were more strongly associated with dominant tumors (rate ratio [RR] = 0.60, 0.83, 1.58 and 1.37, respectively) than nondominant tumors (RR = 1.03, 0.93, 0.84 and 1.14, respectively; p-difference = 0.0001, 0.01, 0.0003 and 0.01, respectively). These data suggest that risk factors for tumors putatively arising from ovarian versus fallopian tube sites may differ; in particular, reproductive factors may be more important for ovarian-derived tumors. As this is the first study to evaluate ovarian cancer risk factors by tumor dominance, these results need to be validated by other studies.
基于发育途径对卵巢肿瘤进行分类可能会进一步加深我们对疾病的认识。传统上,卵巢癌被认为起源于卵巢表面上皮;然而,最近的证据表明,一些肿瘤起源于输卵管。我们通过肿瘤优势(一种组织起源的替代指标)对基于人群的病例对照研究(新英格兰病例对照研究 [NECC] 研究)和两项队列研究(护士健康研究 [NHS]/护士健康研究 II [NHSII])中的病例进行分类。优势肿瘤(可能为卵巢来源)局限于单侧卵巢,或者单侧卵巢上的肿瘤至少比另一侧大两倍。使用多分类逻辑回归(NECC)或竞争风险 Cox 模型(NHS/NHSII)评估卵巢癌危险因素与优势肿瘤(可能为输卵管来源)和非优势肿瘤(可能为输卵管来源)的关系。结果采用随机效应荟萃分析进行合并。在 1771 例浸润性上皮性卵巢癌病例中,我们观察到 1089 例肿瘤有优势肿块,682 例无优势肿块。优势肿瘤更可能为黏液性、子宫内膜样或透明细胞性,而非优势肿瘤更可能为浆液性。输卵管结扎术、两次或更多次分娩、子宫内膜异位症和年龄与优势肿瘤(RR=0.60、0.83、1.58 和 1.37)的相关性强于非优势肿瘤(RR=1.03、0.93、0.84 和 1.14;p 差异=0.0001、0.01、0.0003 和 0.01)。这些数据表明,假定来源于卵巢与输卵管部位的肿瘤的危险因素可能不同;特别是,生殖因素可能对卵巢来源的肿瘤更为重要。由于这是第一项按肿瘤优势评估卵巢癌危险因素的研究,因此这些结果需要其他研究进行验证。